# Efficacy of Intravenous Immunoglobulin in Patients With Hemorrhagic Fever With Renal Syndrome: a Prospective Study

> **NCT06009042** · PHASE4 · UNKNOWN · sponsor: **Tongji Hospital** · enrollment: 100 (estimated)

## Conditions studied

- HFRS (Hemorrhagic Fever With Renal Syndrome)

## Interventions

- **DRUG:** IVIG 20g/d
- **DRUG:** IVIG 10g/d

## Key facts

- **NCT ID:** NCT06009042
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06009042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06009042, "Efficacy of Intravenous Immunoglobulin in Patients With Hemorrhagic Fever With Renal Syndrome: a Prospective Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06009042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*